Navigation Links
Arete Therapeutics Initiates Phase IIa Clinical Trial for AR9281, a Novel s-EH Inhibitor to Treat Type 2 Diabetes
Date:2/10/2009

>

"AR9281 operates within the third branch of the arachidonic acid pathway and represents a potentially more specific and selective approach to intervene in metabolic and inflammatory diseases. The first two branches of this critical regulatory pathway have been targeted by several commercially successful marketed anti-inflammatory drugs including Aspirin(R) (acetylsalicylic acid), Motrin(R) (ibuprofen), Singulair(R) (Montelukast) and Celebrex(R) (celecoxib). We designed our Phase IIa trial to further validate the role of s-EH in the pathophysiology of disease and to lay the groundwork for further exploration of s-EH inhibition in treating a broad range of serious diseases including type 2 diabetes, hypertension and inflammatory disorders," commented Randall Whitcomb, M.D., Chief Medical Officer of Arete.

The results of a Phase I clinical program consisting of two double-blind, placebo-controlled studies demonstrated that AR9281 was safe and well tolerated in healthy volunteers. The studies met all safety, tolerability, pharmacokinetic and pharmacodynamic endpoints. In addition, AR9281 has shown favorable results in various published and proprietary in vitro and in vivo assays for potency, selectivity, efficacy, ADME, toxicity and safety.

About Arete Therapeutics Inc.

Arete Therapeutics is a privately-held biotechnology company dedicated to the discovery and development of novel drugs to treat type 2 diabetes, hypertension and inflammatory disorders. It is the world's leading company focused on s-EH, an important enzyme for the metabolism of arachidonic acid that plays an essential role in metabolic, inflammatory and cardiovascular physiology. The Company was founded by Dr. Bruce Hammock, a Professor at the University of California, Davis, who discovered s-EH. The Company has raised a total of over $51 million in Series A financing led by Frazier Healthcare Ventures, Alta Part
'/>"/>

SOURCE Arete Therapeutics Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. CareTech Solutions Executive to Conduct Presentation on Creating a Healthy Revenue Cycle at AHIMA Convention and Exhibit
2. Arete Therapeutics Initiates Phase 1 Clinical Trial For AR9281 as a First-in-Class Antihypertensive Agent
3. Arete Therapeutics Appoints Donald Santel to Board of Directors
4. CareTech Solutions Service Desk Equals Help Desk Plus
5. Nationally Recognized Diabetes Specialist Dr. Steven Edelman to Provide Educational Articles on Diabetes to MyCareTeam's Website Community
6. CareTech Solutions Named Best in KLAS for Extensive IT Outsourcing Services
7. EnovateIT Partners with CareTech Solutions to Create a Custom Product for Crittenton Hospital Medical Center, One of the Nation's Most Wired Hospitals
8. Prime Therapeutics Receives TIPPS Certification
9. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
10. Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
11. Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... (PRWEB) August 28, 2014 MarijuanaDoctors.com is ... physician, James Patel M.D. of Livermore, California. As always, ... and most qualified physicians, and in accordance with that, ... patients to Dr. Patel’s practice. , Initially finding his ... young age, Dr. Patel was shaped by his mother’s ...
(Date:8/28/2014)... The need for larger space has become more ... The new location - 4700 Bryant Irvin Court, Fort Worth, ... space than TLC had in the past, as well as ... our new location because it represents a good fit for ... in size compared to the current one, the building itself ...
(Date:8/27/2014)... 2014 Author and orthopedic surgeon William ... on the thrilling adventures of sharp and witty ... is gearing up for a new marketing push in ... novellas , “Prescription: Murder” follows the adventures of ... dodging assassination attempts and thwarting criminals. In the first ...
(Date:8/27/2014)... 28, 2014 Recently, BambooIndustry.com, an innovative company ... announced that new bamboo panels are now offered ... deep discounts for clients worldwide. All people that place an ... rate, from 10 to 30 percent off. , The ... panels. “At the moment, all our new and old customers ...
(Date:8/27/2014)... National Resident Matching Program International (NRMPI) ... Education in Europe (AMEE) Conference being held at the ... September 3, 2014. As an exhibitor, NRMPI will ... share the benefits of its matching services, and discuss ... countries throughout the world. , “Exhibiting at ...
Breaking Medicine News(10 mins):Health News:Army Colonel Dr. James Patel Joins the Medical Marijuana Industry 2Health News:Army Colonel Dr. James Patel Joins the Medical Marijuana Industry 3Health News:Army Colonel Dr. James Patel Joins the Medical Marijuana Industry 4Health News:William H. Simon Launches New Marketing Campaign for Book 2Health News:BambooIndustry.com: Cheap Bamboo Panels for Clients Worldwide Offered Online 2Health News:National Resident Matching Program International (NRMPI) to Exhibit at the 2014 AMEE Conference 2
... WASHINGTON, Sept. 9 As Obama prepares to address the nation ... nation,s Catholic bishops to be prepared to shut down Catholic health ... compromising with the intrinsic evils currently contained in various Obamacare proposals. ... ) , , "Obama speaks tonight. ...
... , A Public Briefing, Saturday, September 19, 2009 , ... , 529 14th Street, NW , Washington D.C. 20045 ... number of organizations are joining in briefings on health care reform that would ... individual rights and choices of Americans. This will provide a stark contrast ...
... UNION CITY, Calif., Sept. 9 Abaxis, Inc. (Nasdaq: ... systems, announced today that Clint Severson, chairman and chief executive officer, ... 2009 on Thursday, September 17, 2009 at 10:00 a.m. ET. The ... New York City. , , About Abaxis ...
... , , , CHICAGO, ... to the long-term care industry, today announced it was named to ... privately held companies in the United States for the third consecutive year. ... 2005 through 2008 and is the only long-term care pharmacy services provider ...
... , CHAPEL HILL, N.C., Sept. 9 TSI ... healthcare information technology, was recently recognized in Inc. Magazine,s ... nation. Some of the most successful and innovative businesses in America ... SAS, Intuit, and Nike. , , ...
... , , CINCINNATI, Sept. 9 ... know that healthful aging depends on our current habits. "Our ... take precautionary measures to strengthen ourselves," explains the women,s health expert ... are all areas that are often overlooked or taken for granted ...
Cached Medicine News:Health News:A.L.L.: Bishops Must Choose Between Christ-Centered Care and Obamacare 2Health News:Joint Briefing on Proposed Health Care Reform 2Health News:Joint Briefing on Proposed Health Care Reform 3Health News:Millennium Pharmacy Systems Named to Inc. 500 for Third Consecutive Year 2Health News:TSI Healthcare Recognized by Inc. Magazine 2Health News:Leading Women's Health Expert Offers Preventive Tips for Healthful Aging 2Health News:Leading Women's Health Expert Offers Preventive Tips for Healthful Aging 3Health News:Leading Women's Health Expert Offers Preventive Tips for Healthful Aging 4
(Date:8/27/2014)... , Aug. 27, 2014  Decision Resources ... specialties (medical oncology, hematology-oncology, rheumatology, gastroenterology, endocrinology and ... trials that a biosimilar has been assessed in ... product they choose to prescribe. ... report entitled Acceptance of Biosimilars Across ...
(Date:8/27/2014)... -- According to the new research ... Chairs, Dental Lasers), Current Trends, Opportunities - Global Forecast ... Market is expected to reach $7,138.9 million by ... a CAGR of 5.7% between 2014 and 2019. ... 61 figures spread through 167 pages and in-depth ...
(Date:8/27/2014)... , Aug. 27, 2014 Reportlinker.com announces ... in its catalogue: Global Heart Valve ... http://www.reportlinker.com/p02316644/Global-Heart-Valve-Repair-and-Replacement-Market-2014-2018.html About Heart Valve ... the human heart which control the flow of ... with heart valve diseases such as valvular stenosis, ...
Breaking Medicine Technology:Surveyed Physicians Expect to Choose Between Future Biosimilars Based on Robustness and Number of Clinical Trials 2Dental Equipment Market Worth $7,138.9 Million by 2019 2Dental Equipment Market Worth $7,138.9 Million by 2019 3Global Heart Valve Repair and Replacement Market 2014-2018 2Global Heart Valve Repair and Replacement Market 2014-2018 3Global Heart Valve Repair and Replacement Market 2014-2018 4
... Inc. (ReGen), manufacturer of the popular and successful Menaflex Collagen ... (FDA) offer of a hearing under 21 CFR Part 16 ... the device. According to ReGen Chair and CEO ... FDA over the past six years makes it clear that ...
... 2011 Terso Solutions, Inc. has expanded its line ... refrigerator that is well-suited for hospital and laboratory ... new refrigerator makes better use of space, reduces energy ... such as reagents, cardiovascular products, tissue samples, and orthopedic ...
Cached Medicine Technology:ReGen to FDA: 'Thanks, But No Thanks' 2ReGen to FDA: 'Thanks, But No Thanks' 3ReGen to FDA: 'Thanks, But No Thanks' 4Terso Solutions Launches New RFID-Enabled Refrigerator for Hospital and Laboratory Inventory Management 2
Black multi-pinhole occluder...
9 inch double ended with one end black and the other end with 49 holes...
Double Ended Occluders...
49 pinholes, black...
Medicine Products: